The U.S. Preventive Services Task Force is continuing to recommend routine mammograms every 2 years for women starting at age 50, according to newly r... More »
The U.S. Preventive Services Task Force is continuing to recommend routine mammograms every 2 years for women starting at age 50, according to newly r... More »
Pembrolizumab was superior to ipilimumab, the standard of care, as first-line therapy for advanced melanoma in the phase III KEYSTONE-006 trial.
Pemb... More »
Medicare is proposing to begin covering human papillomavirus testing once every 5 years in conjunction with the Pap smear test for its asymptomatic fe... More »
Treatment of nine women with metastatic cervical cancer with single infusions of tumor-infiltrating lymphocytes grown out from tumor specimens collect... More »
Treatment of nine women with metastatic cervical cancer with single infusions of tumor-infiltrating lymphocytes grown out from tumor specimens collect... More »
In a population of patients with hematologic malignancies who refuse blood product transfusions, high-dose chemotherapy (HDC) followed by autologous s... More »
SAN FRANCISCO – Pregnancy increases the risk of poor outcomes in melanoma, according to a review of melanoma cases at the Cleveland Clinic.
The ef... More »
SAN FRANCISCO – Pregnancy increases the risk of poor outcomes in melanoma, according to a review of melanoma cases at the Cleveland Clinic.
The ef... More »
Among women who carry BRCA1 or BRCA2 mutations, the type and exact location of the mutation influences the risk it confers for breast and ovarian canc... More »